Addex Therapeutics Ltd

NASDAQ: ADXN · Real-Time Price · USD
8.00
0.48 (6.38%)
At close: Aug 15, 2025, 3:47 PM
7.94
-0.75%
After-hours: Aug 15, 2025, 04:00 PM EDT

Addex Therapeutics Ltd Cash Flow Statement

Financials in CHF. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
8.67M 9.41M 7.76M 6.67M -8.88M -10.56M -11.35M -12.84M -17.39M -20.8M -21.58M -21.07M -18.54M -15.35M -13.05M -12.77M -11.19M
Depreciation & Amortization
191.88K 192.7K 248.28K 270.09K 233.11K 305.95K 302.21K 304.15K 312.09K 323.14K 330.46K 340.88K 345.8K 347.61K 351.72K 362.99K 371.24K
Stock-Based Compensation
116.94K 502.96K 860.91K 1.31M 1.75M 1.79M 2.09M 2.5M 2.67M 3.68M 3.27M 2.75M 2.43M 1.18M 1.13M 1.06M 1.06M
Other Working Capital
-1.86M -2.15M -644.16K -898.45K 238.6K -92.76K -1.87M -1.13M 176.98K 409.77K 1.57M 1.63M -1.34M -665.15K 604.52K 50.12K -1.25M
Other Non-Cash Items
-11.03M -14.8M -14.83M -15.73M -2.2M 653.26K 285.79K 213.38K 136.95K 204.13K 200.72K 355.99K 586.96K 44.95K 174.4K 435.84K 356.21K
Deferred Income Tax
n/a n/a -389.21K -394.47K -403.62K -403.62K -14.42K -9.15K n/a n/a -11.54K 27.31K 39.33K -150.59K -124.74K -144.09K -137.21K
Change in Working Capital
-1.72M -1.14M -84.36K -367.18K 1.22M 213.76K -1.75M -1.05M 313.39K 157.68K 1.48M 1.43M -1.64M -761.57K 473.86K -7.95K -1.25M
Operating Cash Flow
-3.78M -5.37M -5.97M -7.83M -7.83M -7.99M -10.44M -10.88M -13.95M -16.44M -16.31M -16.16M -16.78M -14.71M -11.06M -11.07M -10.79M
Capital Expenditures
-1.27K -1.27K -2.48K -1.88K -4.37K -6.84K -5.64K -5.54K -3.05K -580 -25.07K -26.16K -28.39K -31.55K -55.15K -54.17K -54.06K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a -8 3.55K 3.55K 3.55K 3.65K 1.24K 1.24K 1.24K 1.15K n/a n/a
Other Investing Acitivies
4.65M 4.65M 4.66M 4.67M n/a n/a -8 3.55K 3.55K 3.55K 3.65K 1.24K 1.24K 1.24K 1.15K n/a n/a
Investing Cash Flow
4.65M 4.65M 4.66M 4.67M -4.37K -6.84K -5.65K -1.99K 503.00 2.97K -21.42K -24.92K -27.15K -30.31K -54K -54.17K -54.06K
Debt Repayment
-8.74K -73.69K -140.97K -210.91K -234.51K -281.79K -279.71K -277.71K -327.03K -288.08K -295.01K -303.56K -307.08K -309.62K -321.81K -338.68K -353.41K
Common Stock Repurchased
-21.24K -21.24K -21.24K -39.57K -33.57K -33.57K -33.57K -15.23K -5.03K -13.59K -13.59K -13.59K -8.56K n/a n/a 12.12K -25.02K
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-57.34K -62.29K -1M -1.12M 3.23M 3.2M 4.27M 7.42M 2.79M 2.17M 6.76M 3.71M 3.41M 2.75M -1.91M -1.91M -1.51M
Financial Cash Flow
38.36K 103.65K 47.02K -141.45K 4.4M 5.26M 5.15M 9.53M 4.88M 3.1M 11.43M 7.15M 6.87M 16.4M 8.74M 8.73M 9.05M
Net Cash Flow
1.2M -523.74K -1.4M -3.38M -3.97M -3.09M -5.67M -1.64M -9.29M -13.53M -5.06M -9.3M -10.33M 1.79M -2.33M -2.56M -1.91M
Free Cash Flow
-3.78M -5.37M -5.97M -7.83M -7.83M -8M -10.45M -10.89M -13.96M -16.44M -16.34M -16.18M -16.81M -14.74M -11.11M -11.13M -10.84M